[Therapeutic monitoring and prediction of the efficacy of neurotrophic treatment in patients with amnestic type of mild cognitive impairment].

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/jnevro20171178127-38PMID 28884714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Naturally occurring Antibodies against Synthetic Fragment of Neurotrophin Receptor P75 in Sera of Cognitively Impaired Patients

  2016cited by this paper
• [The reduced level of antibodies to acetylcholine receptor alpha 7 fragment in the blood serum of patients with Alzheimer's disease].

  2015cited by this paper
• ИММУНИЗАЦИЯ СИНТЕТИЧЕСКИМ ФРАГМЕНТОМ РЕЦЕПТОРА НЕЙРОТРОФИНОВ Р75 ПРЕДОТВРАЩАЕТ ПОТЕРЮ ПРОСТРАНСТВЕННОЙ ПАМЯТИ И СНИЖАЕТ УРОВЕНЬ БЕТА-АМИЛОИДА У МЫШЕЙ С ЭКСПЕРИМЕНТАЛЬНО ИНДУЦИРОВАННОЙ ФОРМОЙ БОЛЕЗНИ АЛЬЦГЕЙМЕРА

  2014cited by this paper
• Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat

  2014cited by this paper
• The biological functions and signaling mechanisms of the p75 neurotrophin receptor.

  2014cited by this paper
• [Immunization witha synthetic fragment 155-164 of neurotrophin receptor p75 prevents memory loss and decreases beta-amyloid level in mice with experimentally induced Alzheimer's disease].

  2014cited by this paper
• Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

  2013cited by this paper
• Sonic Hedgehog Signaling Pathway Mediates Cerebrolysin-Improved Neurological Function After Stroke

  2013cited by this paper
• [A study of neuroregenerative action of cerebrolysin in brain trauma].

  2013cited by this paper
• Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor

  2013cited by this paper
• Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats

  2013cited by this paper
• Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice

  2012cited by this paper
• Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neurotoxicity: modulatory roles of co-morbidity factors and nanoparticle intoxication.

  2012cited by this paper
• Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease

  2011cited by this paper
• Brain-Reactive Autoantibodies Prevalent in Human Sera Increase Intraneuronal Amyloid-β1-42 Deposition

  2011cited by this paper
• Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil.

  2011cited by this paper
• Vaccination with Peptide 173-193 of Acetylcholine Receptor α7-Subunit Prevents Memory Loss in Olfactory Bulbectomized Mice

  2010cited by this paper
• The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo

  2009cited by this paper
• Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection

  2009cited by this paper
• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

  2007cited by this paper
• Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients.

  2002cited by this paper
• Therapeutic results with Cerebrolysin in the treatment of dementia.

  1997cited by this paper
• Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system

  1994cited by this paper
• Studies of neuroimmune markers in Alzheimer's disease

  1994cited by this paper
• Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).

  1994cited by this paper
• Neuron-binding antibodies in Alzheimer's disease and Down's syndrome.

  1989cited by this paper

• Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients

  2025cites this paper
• Towards a WPA Position Document on the Human Rights of Older Adults with Mental Health Conditions

  2022cites this paper
• The Evolution of Diagnostic Boundaries of Alzheimer’s Disease and Novel Therapeutic Options

  2022cites this paper
• [Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment].

  2022cites this paper
• [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].

  2022cites this paper
• Neurotrophins and Neurotrophic Therapy (Based on the Cerebrolysin Model) in the Treatment of Elderly Patients with Cognitive Disorders and Depression. Part 1

  2021cites this paper
• Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

  2020influential citation
• Cerebrolysin for vascular dementia.

  2019cites this paper
• Сочетание нейродегенеративных и сосудистых механизмов в патогенезе деменций позднего возраста

  2017cites this paper